Precision Announces 3-Year Pre-clinical Study Results Showing Long-term Durability and Safety of ARCUS In Vivo Gene Editing to Cut LDL Cholesterol Levels in Nonhuman Primates

Author's Avatar
Feb 19, 2021
Article's Main Image

Study Led by Gene Therapy Program at the University of Pennsylvania Published in Molecular Therapy